Search Legislation

Directive 2002/98/EC of the European Parliament and of the CouncilShow full title

Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC

 Help about what version

What Version

 Help about advanced features

Advanced Features

More Resources

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Changes over time for: Directive 2002/98/EC of the European Parliament and of the Council (Annexes only)

 Help about opening options

Status:

EU Directives are being published on this site to aid cross referencing from UK legislation. After IP completion day (31 December 2020 11pm) no further amendments will be applied to this version.

ANNEX IU.K.INFORMATION TO BE PROVIDED BY BLOOD ESTABLISHMENT TO THE COMPETENT AUTHORITY FOR THE PURPOSES OF DESIGNATION, AUTHORISATION, ACCREDITATION OR LICENSING IN ACCORDANCE WITH ARTICLE 5(2)

Part A:U.K.General information:

  • identification of the blood establishment

  • name, qualification and contact details of responsible persons

  • a list of hospital blood banks which it supplies.

Part B:U.K.A description of the quality system, to include:

  • documentation, such as an organisation chart, including responsibilities of responsible persons and reporting relationships

  • documentation such as site master file or quality manual describing the quality system in accordance with Article 11(1)

  • number and qualifications of personnel

  • hygiene provisions

  • premises and equipment

  • list of standard operating procedures for recruitment, retention and assessment of donors, for processing and testing, distribution and recall of blood and blood components and for the reporting and recording of serious adverse reactions and events.

ANNEX IIU.K.REPORT OF THE BLOOD ESTABLISHMENT'S PRECEDING YEAR'S ACTIVITY

This annual report will include:

  • total number of donors who give blood and blood components

  • total number of donations

  • an updated list of the hospital blood banks which it supplies

  • total number of whole donations not used

  • number of each component produced and distributed

  • incidence and prevalence of transfusion transmissible infectious markers in donors of blood and blood components

  • number of product recalls

  • number of serious adverse events and reactions reported.

ANNEX IIIU.K.LABELLING REQUIREMENTS

The label on the component must contain the following information:

  • the official name of the component

  • the volume or weight or number of cells in the component (as appropriate)

  • the unique numeric or alphanumeric donation identification

  • the name of producing blood establishment

  • the ABO Group (not required for plasma intended only for fractionation)

  • the Rh D Group, either Rh D positive or Rh D negative (not required for plasma intended only for fractionation)

  • the date or time of expiry (as appropriate)

  • the temperature of storage

  • the name, composition and volume of anticoagulant and/or additive solution (if any).

ANNEX IVU.K.BASIC TESTING REQUIREMENTS FOR WHOLE BLOOD AND PLASMA DONATIONS

The following tests must be performed for whole blood and apheresis donations, including autologous predeposit donations:

  • ABO Group (not required for plasma intended only for fractionation)

  • Rh D Group (not required for plasma intended only for fractionation)

  • testing for the following infections in the donors:

    • Hepatitis B (HBs-Ag)

    • Hepatitis C (Anti-HCV)

    • HIV 1/2 (Anti-HIV 1/2)

Additional tests may be required for specific components or donors or epidemiological situations.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources